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Strongyloides stercoralis hyperinfection syndrome is a medical emergency requiring 
a high level of suspicion. Immunocompromised patients are particularly at high risk of 
hyperinfection syndrome; however, malnutrition, alcoholism, and diabetes mellitus 
also need to be considered as predisposing factors. Diagnosis and treatment of 
Strongyloides hyperinfection are challenging, and patients with this disease often 
have severe complications. Consequently, mortality is overwhelmingly high, with 
rates above 60%. Herein, we report a case of Strongyloides hyperinfection in a 40-
year-old alcoholic, diabetic patient, who lived in Mexico. Unfortunately, the late 
diagnosis resulted in fatality despite treatment and supportive measures. Increased 
awareness is needed to prevent the dire consequences of strongyloidiasis. 
Keywords: Strongyloides stercoralis; strongyloidiasis; neglected diseases; Mexico. 
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El síndrome de hiperinfección por Strongyloides stercoralis es una emergencia 
médica que requiere mayor sospecha clínica. Los pacientes inmunocomprometidos 
tienen alto riesgo de síndrome de hiperinfección; sin embargo, la desnutrición, el 
alcoholismo y la diabetes mellitus también deben considerarse factores 
predisponentes. El diagnóstico y el tratamiento de la hiperinfección por Strongyloides 
son desafiantes, y los pacientes con esta enfermedad a menudo tienen 
complicaciones graves. Como consecuencia, la mortalidad es abrumadoramente 
alta, con tasas superiores al 60%. Aquí, presentamos un caso de hiperinfección por 
Strongyloides en un paciente diabético y alcohólico de 40 años, que vivía en México. 
Infortunadamente, el diagnóstico tardío causó su muerte a pesar del tratamiento y 
las medidas de soporte. Se necesita un mayor conocimiento para prevenir las 
terribles consecuencias de la estrongiloidiasis. 
Palabras clave: Strongyloides stercoralis; estrongiloidiasis; enfermedades 
desatendidas; México. 
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Strongyloidiasis is a neglected parasitic disease mainly caused by Strongyloides 
stercoralis, and to a lesser extent, by S. fuelleborni. It is estimated to affect at least 
370 million people worldwide, especially in tropical and subtropical regions (1,2). 
Although there is a lack of updated and comprehensive epidemiological data for S. 
stercoralis, strongyloidiasis is considered to be largely endemic to Mexico. In a few 
community- and hospital-based surveys, the prevalence of S. stercoralis has been 
estimated from 0.1% to 68% (3-5). 
S. stercoralis has a complex life cycle with both free-living and parasitic 
developmental stages including autoinfection (1,6,7). Rhabditiform larvae (L1, usual 
diagnostic stage) are passed in the stool after hatching from eggs deposited in the 
intestinal mucosa of an infected definitive host (human or dog). These larvae develop 
directly or indirectly into filariform larvae (L3, infective stage) that penetrate the intact 
skin after contact with contaminated soil. Filariform larvae migrate via the 
bloodstream and lymphatics to the lungs, from where they ascend the 
tracheobronchial tree and are swallowed to reach the gastrointestinal tract. In the 
small intestine, larvae mature into adult female worms, which live embedded in the 
submucosa and produce eggs via parthenogenesis, yielding rhabditiform larvae. 
These larvae can either be excreted in the stool or can become filariform larvae and 
penetrate intestinal mucosa or perianal skin, resulting in autoinfection. 
The unique life cycle of S. stercoralis is determinant for the presentation forms in 
infected persons. Infection ranges from asymptomatic to chronic symptomatic 
strongyloidiasis and to the severe/disseminated forms of the disease (7). Herein, we 
report a fatal case of S. stercoralis hyperinfection in a hypoalbuminemic, alcoholic, 
and diabetic patient from Mexico.  
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Case presentation 
A 40-year-old Mexican-born male with a history of homelessness was admitted to a 
hospital in Monterrey, Mexico, for abdominal pain and vomiting of 2 weeks’ duration. 
The patient complained of a 10 kg weight loss in the previous month. The patient 
originally came from a low-income area in Oaxaca and had been living in Monterrey 
for the last 5 years. He had a history of alcoholism and diabetes mellitus. He did not 
take any medications. On examination, he was afebrile, tachycardic, dehydrated, and 
with normal oxygen saturation. The pulmonary examination was unremarkable. He 
had a distended, slightly tender abdomen with diminished bowel sounds. His white 
blood cell count was 16,200/µL with 92.3% neutrophils and 0.66% eosinophils 
(107/µL). Hemoglobin was 10.4 g/dL and plasma glucose was 133 mg/dL. 
Hyponatremia and hypokalemia were noted. Serum total proteins and albumin were 
low (5.3 g/dL and 2.3 g/dL, respectively). An abdominal X-ray showed dilated small 
bowel loops suggestive of paralytic ileus. The initial treatment consisted of fluid 
resuscitation and placement of a nasogastric tube. On hospital day 3, his persistent 
ileus prompted the surgery service to perform a laparotomy. 
Over the next 48 hours, the patient presented shortness of breath, hemoptysis, and 
fever. A chest X-ray revealed bilateral diffuse interstitial infiltrates (Figure 1), and the 
patient was empirically started on imipenem/cilastatin and vancomycin for presumed 
bacteremia. Due to clinical worsening, he underwent bronchoscopy with 
bronchoalveolar lavage (BAL), which yielded a bloody lavage fluid from the right 
middle lobe. Pathological examination revealed numerous S. stercoralis filariform 
larvae (Figure 2). Subsequently, stool examination confirmed the presence of 
rhabditiform larvae (Figure 3). Human T-cell lymphotropic virus type-1 (HTLV-1) and 
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human immunodeficiency virus (HIV) serologies were negative. S. stercoralis larvae 
from BAL and feces provided diagnostic proof of hyperinfection syndrome. 
On hospital day 10, the patient was started on oral ivermectin 12 mg daily; however, 
2 days later, ivermectin was given per rectum owing to reduced oral intake. Later that 
day, the patient was taken to surgery for repair of omental evisceration. 
Postoperatively, the patient continued to deteriorate and developed respiratory failure 
requiring mechanical ventilation. He was transferred to the intensive care unit, where 
he died despite treatment and supportive measures. 
Informed consent for this publication and the accompanying images was obtained 
from the patient’s nearest relative. 
Discussion 
Strongyloidiasis can present in a wide variety of forms. In immunocompetent hosts, 
S. stercoralis mostly causes asymptomatic chronic infections that may persist for 
decades because of the ability of the parasite to sustain itself by low-level 
autoinfection. Gastrointestinal and dermatologic complaints, when present, are 
usually mild and include abdominal pain, diarrhea, constipation, vomiting, anorexia, 
urticaria, and larva currens (1,7). In contrast, in immunocompromised hosts, S. 
stercoralis can cause severe, life-threatening conditions resulting from accelerated 
autoinfection: the hyperinfection syndrome, in which numerous larvae are confined to 
the autoinfective cycle (gastrointestinal tract, peritoneum, and lungs), and 
disseminated strongyloidiasis, which is characterized by larval migration to multiple 
organs beyond the range of the autoinfective cycle, including the liver, heart, kidneys, 
brain, and skin. 
Cell-mediated immunosuppression can trigger the massive dissemination of S. 
stercoralis larvae. Several immunosuppression-related risk factors for Strongyloides 
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hyperinfection have been described, including the use of corticosteroids and other 
immunosuppressants, HTLV-1 infection, organ transplantation, and hematologic 
malignancies (1,7). Other predisposing factors are malnutrition, alcoholism, and 
diabetes mellitus (1,8,9). These 3 conditions were present in the patient reported. 
Interestingly, it has been postulated that the increased predisposition to S. stercoralis 
infection in alcoholics is related to reduced intestinal motility and increasing 
endogenous cortisol levels resulting in a deficient type 2 T helper cells (Th2) immune 
response as well as in ecdysteroid-mimicking effects (8,10). 
The increased larval burden in hyperinfection syndrome explains the development or 
exacerbation of gastrointestinal and respiratory symptoms. Cough, dyspnea, 
wheezing, and hemoptysis are common. Fever and neurologic manifestations may 
be present and should prompt a search for sepsis and meningitis due to translocation 
of enteric bacteria facilitated by worm migration (7). Patients with S. stercoralis 
hyperinfection often have severe complications such as paralytic ileus, bowel 
obstruction, bacteremia, meningitis, respiratory failure, and multiorgan dysfunction 
(1). Consequently, mortality is overwhelmingly high with rates above 60% (1,7,11,12). 
Diagnosis of hyperinfection syndrome requires a high level of suspicion. The 
detection of S. stercoralis filariform larvae in sputum or BAL fluid is the hallmark of 
hyperinfection syndrome (7). Contrary to asymptomatic and chronic forms of 
strongyloidiasis, microscopic examination of stool in patients with hyperinfection has 
increased sensitivity and often reveals numerous larvae (7,11). As seen in our case, 
eosinophilia is frequently absent in the hyperinfection syndrome (66-75%) (11,12). 
The treatment of choice is ivermectin (200 µg/kg/day) based on its efficacy and 
favorable side-effect profile. Oral daily dosing is recommended for at least 2 weeks 
after parasite clearance from stools (7,13). Because many patients are critically ill or 
10 
experience paralytic ileus, enteral absorption may be impaired. Therefore, 
unorthodox administration routes (subcutaneous and rectal) have been attempted as 
adjunct or alternative to oral ivermectin. However, parenteral ivermectin is currently 
only available as a veterinary preparation and is not licensed for human use (14). 
There is a need for improved access to parenteral ivermectin and more data from 
pharmacological studies and clinical trials to guide treatment of severe 
strongyloidiasis. 
In conclusion, Strongyloides hyperinfection syndrome is a medical emergency 
requiring a high level of suspicion. Immunocompromised patients are particularly at 
high risk of hyperinfection syndrome; however, malnutrition, alcoholism, and diabetes 
mellitus also need to be considered as predisposing factors. Since both diagnosis 
and treatment are challenging, patients frequently have poor outcomes. Our patient 
lived in an endemic area and had multiple risk factors for Strongyloides 
hyperinfection. Unfortunately, his ileus worsened shortly after the admission and the 
diagnosis was late, resulting in fatality despite treatment and supportive measures. 
This case highlights the importance of awareness and suspicion of strongyloidiasis in 
individuals with impaired immunity or underlying risk conditions, especially if present 
or past exposure to endemic areas is reported, as well as early diagnosis and 
treatment of hyperinfection syndrome. 
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Figure 1. Chest x-ray showing bilateral diffuse interstitial infiltrates. 
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Figure 2. H&E stain on a bronchoalveolar lavage specimen showing a Strongyloides 
stercoralis filariform larva (100X). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15 
Figure 3. Wet mount of stool stained with methylene blue showing a Strongyloides 
stercoralis rhabditiform larva (100X). Rhabditoid esophagus can be appreciated. 
